Tetra Bio-Pharma Provides Update on its Neuropathic and Chronic Pain Drug Development Program
Tetra Bio-Pharma Inc. today announced accelerated development of its second-generation drug inhalation program for fibromyalgia and uncontrolled pain over the last months.